George M Milne Jr's Net Worth
$29.1 Million
Who is George M Milne Jr?
George M Milne Jr has an estimated net worth of $29.1 Million. This is based on reported shares across multiple companies, which include Amylyx Pharmaceuticals, Inc., Aurinia Pharmaceuticals Inc., CONOR MEDSYSTEMS INC, BTHC VI Inc, MEDIMMUNE INC /DE, METTLER TOLEDO INTERNATIONAL INC/, and CHARLES RIVER LABORATORIES INTERNATIONAL INC.
SEC CIK
George M Milne Jr's CIK is 0001179552
Past Insider Trading and Trends
2015 was George M Milne Jr's most active year for acquiring shares with 10 total transactions. George M Milne Jr's most active month to acquire stocks was the month of April. 2015 was George M Milne Jr's most active year for disposing of shares, totalling 15 transactions. George M Milne Jr's most active month to dispose stocks was the month of January. 2007 saw George M Milne Jr paying a total of $1,084,400.00 for 121,200 shares, this is the most they've acquired in one year. In 2015 George M Milne Jr cashed out on 41,504 shares for a total of $3,275,306.36, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Amylyx Pharmaceuticals, Inc. (AMLX) Snapshot price: $2.37
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +13.18% | 100K |
$2.20 | $219,800.00 | 858.57K |
Sep 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
| -1.19% | -9.10K |
—
|
—
| 758.57K |
Jan 25
| |||
Form 4
| -10.95% | -94.35K |
—
|
—
| 767.67K |
Jan 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
| -3.90% | -35.00K |
$31.89 | -$1,116,072.45 | 862.02K |
Mar 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
| +13.49% | 26.32K |
$19.00 | $499,985.00 | 221.4K |
Jan 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Aurinia Pharmaceuticals Inc. (AUPH) Snapshot price: $7.4
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +12.48% | 8.73K |
—
|
—
| 78.73K |
May 18
| |||
Form 4
| +40.00% | 20K |
$8.91 | $178,284.00 | 70K |
Mar 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 18
| |||
Form 4
| +11.11% | 5K |
$10.82 | $54,100.00 | 50K |
Mar 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
| +12.50% | 5K |
$13.00 | $65,000.00 | 45K |
Mar 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CONOR MEDSYSTEMS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
|
∞
| 1.04M |
—
|
—
| 1.04M |
Dec 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
BTHC VI Inc (ATHX) Snapshot price: $0.025
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
| +94.50% | 1.61M |
$5.00 | $8,050,000.00 | 3.31M |
Jun 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
MEDIMMUNE INC /DE No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||